Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc (“Alltracel”), where he built a team which oversaw numerous patents granted on refined cellulose. Alltracel was admitted to trading on AIM in 2001. In 2004, he was appointed as a Managing Partner for Farmabrand Private Equity. In March 2020, he was appointed as a Non-executive Chairman to Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020. Gerard is a Fellow of the Ryan Academy of Entrepreneurs in Dublin.

Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Investment Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc.

Robert is Non-executive Chairman of AIM quoted Mobile Streams plc. He has acted as Head of International Legal Affairs at Enterprise Oil plc (a UK FTSE 100 company prior to its acquisition by Shell in 2002) and as co-founder and Commercial Director of Granby Oil & Gas plc, which was listed on AIM from 2005 until its sale in 2008. Robert subsequently co-founded a specialist private pipeline installation company operating in the Middle East, and is Managing Director of, private energy exploration Ardent Oil group of companies based in Luxembourg and UK. He is also a co-founder of a component manufacturer start-up company Digital Metals Ltd. Robert is a UK qualified barrister and brings to the board over 35 years’ commercial, legal and entrepreneurial experience at an international level.

Anthony, of Strategic Finance Director Ltd (Company Secretary), has over 22 years’ experience directing or advising over 40 high growth potential businesses of differing size and complexity and brings broad experience of strategic, operational, and financial matters. His career encompasses numerous businesses in the life sciences and healthcare sector including 6 years as Chief Financial Officer of AIM quoted Futura Medical Plc where he was involved in its IPO and a series of placings. Previously, Anthony worked with KPMG and PwC on a range of corporate finance matters including fundraisings, company sales and acquisition advice. Anthony has a B.Sc. (Hons) in Natural Sciences from Durham University and is a Qualified Chartered Accountant. Although Anthony is not a director of the Company, he provides invaluable advice on all matters financial.

Phil joined Microsaic Systems plc in 2014 as Engineering Manager, prior to being appointed Operations Director in 2017. Phil has held senior positions across fortune 500, medium and small-scale companies, operating in the high technology capital equipment sectors. Phil joined Microsaic from Oxford Instruments, Plasma Technology, a global provider of plasma tools used in the creation of MEMs devices, where he held the position of Engineering and Technology Director. Prior to this, Phil held senior positions, including programme management, New Product Introduction, Manufacturing Engineering and Operations at Applied Materials Inc.(Implant Division), a global leader in nano-manufacturing technology solutions and a supplier of semiconductor capital equipment,. A Graduate of the Warwick Manufacturing Group, he attained a Master’s Degree in Engineering Business Management and a First class BEng honors degree.

Richard joined Microsaic Systems in 2003 as a Product Engineer and progressed to Devices Manager. From 2006, he led a development team to make miniaturised, chip-based components using Micro-Electro-Mechanical Systems (MEMS) technology and has an extensive network of senior level relationships within micromachining fabs across the world. From 2010 he was Commercial manager supporting marketing-, sales- and servicing-related NPI activities of the MiD. Since 2016 Richard has moved into molecular diagnostics, establishing key strategic relationships with Biopharma. Between 2000 and 2003, Richard worked in various R&D and manufacturing sites at Agilent Technologies. He was awarded a BSc degree in Physics and Chemistry of Materials from the University of Durham, and obtained a PhD in Device Physics at the University of Cambridge.

Victoria joined Microsaic as applications engineer in 2015. Victoria has extensive knowledge in Mass Spectrometry, Liquid Chromatography-Mass Spectrometry (LC-MS), GMP and Analytical Chemistry.
Victoria graduated from Edinburgh University in 2013 where she was awarded a Masters in Chemistry. As part of her degree at Edinburgh she did a year in industry in their clinical applications lab at Waters and her masters project focused on the mass spectrometry of multimeric protein complexes. After graduating Victoria worked for Vista Analytical an environmental lab based in California doing environmental LCMS method development.

Steve Vigar has more than 20 years’ experience within the instrumentation industry, where he has held critical service roles in medical research and analytical instrumentation. Steve spent a significant time at Shimadzu, where he held the role of Regional Service manager for the UK. Steve joined Microsaic Systems plc, in July 2013 as Global Service Manager.